Devyser Diagnostics AB (DVYSR) — Capital Reinvestment Ratio
Latest as of March 2026:
0.02x
Devyser Diagnostics AB (DVYSR) has a Capital Reinvestment Ratio of 0.02x as of March 2026, meaning it reinvests 0% of its operating cash flow (Skr12.10 Million) in capital expenditures (Skr300.00K). See how much free cash does Devyser Diagnostics AB generate to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
0.02x
Capex / Operating Cash Flow
Operating Cash Flow
Skr12.10 Million
SEK
Capital Expenditures
Skr300.00K
SEK
Data as of
Mar 2026
Most recent filing
Devyser Diagnostics AB Capital Reinvestment Ratio (2018–2025)
This chart tracks Devyser Diagnostics AB's Capital Reinvestment Ratio across 4 annual periods.
Annual Capital Reinvestment Ratio for Devyser Diagnostics AB (2018–2025)
Year-by-year Capital Reinvestment Ratio for Devyser Diagnostics AB from 2018 to 2025. For live market cap and broader valuation context, see how much is Devyser Diagnostics AB worth.
| Year | Reinvestment Ratio | Operating CF (SEK) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.18x | Skr8.20 Million | Skr1.50 Million | ▼ -96.6% |
| 2020 | 5.44x | Skr627.00K | Skr3.41 Million | ▲ +755.5% |
| 2019 | 0.64x | Skr14.63 Million | Skr9.31 Million | ▼ -24.3% |
| 2018 | 0.84x | Skr6.02 Million | Skr5.06 Million | — |
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow